• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗转铁蛋白受体单链抗体片段(scFv)和双特异性单链抗体片段(bsFv)的制备与鉴定

Preparation and identification of scFv and bsFv against transferrin receptor.

作者信息

Liu Jing, Xiao Daiwen, Zhou Xiaoou, Wen Xue, Dai Hong, Wang Zhihua, Shen Xin, Dai Wei, Yang Daofeng, Shen Guanxin

机构信息

Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

出版信息

J Huazhong Univ Sci Technolog Med Sci. 2008 Dec;28(6):621-5. doi: 10.1007/s11596-008-0601-z. Epub 2008 Dec 24.

DOI:10.1007/s11596-008-0601-z
PMID:19107352
Abstract

To obtain single chain variable fragment (scFv) and bivalent single chain variable fragment (bsFv) against transferrin receptor, up-stream and down-stream primers were designed according to the complementary sequences of FR1 region of variable heavy (VH) and FR4 of variable light (VL), respectively, which contained inter-linker G4S and the restriction endonuclease SfiI, AscI and NotI. Two pieces of scFv fragments were first amplified through PCR and then inserted into plasmid pAB1, which could express scFv protein once induced by IPTG in the host bacteria. To express scFv and bsFv, E. coli TG1 was cultured in LB broth and was induced by IPTG. The restriction enzyme digestion map and DNA sequencing demonstrated that scFv and bsFv genes were successfully inserted into the expression plasmid. SDS-PAGE and Western blotting revealed the protein band at 35kD and 60kD, which were consistent with the molecular weight of scFv and bsFv respectively. Flow cytometry showed that scFv and bsFv harbored the specific binding activity with TfR expressed in various tumor cells, and the avidity of bsFv was higher than that of the parent scFv.

摘要

为了获得抗转铁蛋白受体的单链可变片段(scFv)和二价单链可变片段(bsFv),分别根据可变重链(VH)的FR1区域和可变轻链(VL)的FR4的互补序列设计上下游引物,其中包含连接子G4S以及限制性内切酶SfiI、AscI和NotI。首先通过PCR扩增两条scFv片段,然后将其插入质粒pAB1中,该质粒在宿主细菌中经IPTG诱导后可表达scFv蛋白。为了表达scFv和bsFv,将大肠杆菌TG1在LB肉汤中培养并经IPTG诱导。限制性酶切图谱和DNA测序表明scFv和bsFv基因已成功插入表达质粒。SDS-PAGE和蛋白质印迹显示在35kD和60kD处有蛋白条带,分别与scFv和bsFv的分子量一致。流式细胞术表明scFv和bsFv与各种肿瘤细胞中表达的TfR具有特异性结合活性,且bsFv的亲和力高于亲本scFv。

相似文献

1
Preparation and identification of scFv and bsFv against transferrin receptor.抗转铁蛋白受体单链抗体片段(scFv)和双特异性单链抗体片段(bsFv)的制备与鉴定
J Huazhong Univ Sci Technolog Med Sci. 2008 Dec;28(6):621-5. doi: 10.1007/s11596-008-0601-z. Epub 2008 Dec 24.
2
Generation and functional characterization of the anti-transferrin receptor single-chain antibody-GAL4 (TfRscFv-GAL4) fusion protein.抗转铁蛋白受体单链抗体-GAL4(TfRscFv-GAL4)融合蛋白的构建及功能鉴定。
BMC Biotechnol. 2012 Nov 28;12:91. doi: 10.1186/1472-6750-12-91.
3
Construction of single chain Fv antibody against transferrin receptor and its protein fusion with alkaline phosphatase.抗转铁蛋白受体单链Fv抗体的构建及其与碱性磷酸酶的蛋白融合
World J Gastroenterol. 2005 Jun 7;11(21):3300-3. doi: 10.3748/wjg.v11.i21.3300.
4
Construction, expression and in vitro biological behaviors of Ig scFv fragment in patients with chronic B cell leukemia.慢性B淋巴细胞白血病患者中Ig单链抗体片段的构建、表达及体外生物学行为
J Huazhong Univ Sci Technolog Med Sci. 2006;26(2):157-60, 171. doi: 10.1007/BF02895803.
5
[Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].[抗人宫颈癌小鼠单链可变片段抗体的表达、结构预测及功能分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2006 Jan;26(1):16-21.
6
[Construction and expression of anti-human AFP ScFv gene in BL-21 (DE3) E. coli].抗人甲胎蛋白单链抗体基因在BL-21(DE3)大肠杆菌中的构建与表达
Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 Jan;36(1):20-3.
7
[Cloning and expression of single chain Fv gene against human colorectal carcinoma].[抗人结直肠癌单链Fv基因的克隆与表达]
Ai Zheng. 2002 Jul;21(7):740-4.
8
[Cloning of the variable region genes from hybridoma against HAAH and then construction and expression of anti-HAAH scFv].[抗HAAH杂交瘤可变区基因的克隆及抗HAAH单链抗体的构建与表达]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 May;26(5):467-70.
9
Soluble expression of single-chain variable fragment (scFv) in Escherichia coli using superfolder green fluorescent protein as fusion partner.利用超级折叠绿色荧光蛋白作为融合伴侣在大肠杆菌中可溶性表达单链可变片段 (scFv)。
Appl Microbiol Biotechnol. 2019 Aug;103(15):6071-6079. doi: 10.1007/s00253-019-09925-6. Epub 2019 Jun 7.
10
Single-chain variable fragment antibody against human aspartyl/asparaginyl beta-hydroxylase expressed in recombinant Escherichia coli.在重组大肠杆菌中表达的抗人天冬酰胺酰/天冬氨酰β-羟化酶单链可变片段抗体。
Hybridoma (Larchmt). 2011 Feb;30(1):69-79. doi: 10.1089/hyb.2010.0070.

引用本文的文献

1
Generation and functional characterization of the anti-transferrin receptor single-chain antibody-GAL4 (TfRscFv-GAL4) fusion protein.抗转铁蛋白受体单链抗体-GAL4(TfRscFv-GAL4)融合蛋白的构建及功能鉴定。
BMC Biotechnol. 2012 Nov 28;12:91. doi: 10.1186/1472-6750-12-91.

本文引用的文献

1
Binding specificity and internalization properties of an antibody-avidin fusion protein targeting the human transferrin receptor.靶向人转铁蛋白受体的抗体-抗生物素蛋白融合蛋白的结合特异性和内化特性
J Control Release. 2007 Dec 4;124(1-2):35-42. doi: 10.1016/j.jconrel.2007.08.020. Epub 2007 Aug 25.
2
Antigen-binding characteristics of AbCD71 and its inhibitory effect on PHA-induced lymphoproliferation.AbCD71的抗原结合特性及其对PHA诱导的淋巴细胞增殖的抑制作用。
Acta Pharmacol Sin. 2007 Oct;28(10):1659-64. doi: 10.1111/j.1745-7254.2007.00623.x.
3
Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
TRF1[校正后]和TRF2对端粒保护蛋白的调节与端粒酶相互作用以维持非小细胞肺癌中的端粒长度。
Lung Cancer. 2007 Dec;58(3):310-6. doi: 10.1016/j.lungcan.2007.06.019. Epub 2007 Aug 2.
4
Downregulation of transferrin receptor surface expression by intracellular antibody.细胞内抗体对转铁蛋白受体表面表达的下调作用。
Biochem Biophys Res Commun. 2007 Mar 23;354(4):864-71. doi: 10.1016/j.bbrc.2007.01.052. Epub 2007 Jan 22.
5
The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells.转铁蛋白受体第二部分:治疗药物向癌细胞的靶向递送。
Clin Immunol. 2006 Nov;121(2):159-76. doi: 10.1016/j.clim.2006.06.006. Epub 2006 Aug 17.
6
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.转铁蛋白受体第一部分:生物学特性及用细胞毒性抗体靶向治疗癌症
Clin Immunol. 2006 Nov;121(2):144-58. doi: 10.1016/j.clim.2006.06.010. Epub 2006 Aug 10.
7
A tumor-targeted nanodelivery system to improve early MRI detection of cancer.一种用于改善癌症早期磁共振成像检测的肿瘤靶向纳米递送系统。
Mol Imaging. 2006 Jan-Mar;5(1):41-52.
8
The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor.抗转铁蛋白受体人鼠嵌合抗体的体外抗肿瘤作用及体内肿瘤特异性分布
Cancer Immunol Immunother. 2006 Sep;55(9):1111-21. doi: 10.1007/s00262-005-0105-7. Epub 2005 Dec 8.
9
Construction of single chain Fv antibody against transferrin receptor and its protein fusion with alkaline phosphatase.抗转铁蛋白受体单链Fv抗体的构建及其与碱性磷酸酶的蛋白融合
World J Gastroenterol. 2005 Jun 7;11(21):3300-3. doi: 10.3748/wjg.v11.i21.3300.
10
A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery.人生物素受体结构域可实现酶与抗体-抗生物素蛋白融合蛋白的位点特异性缀合,用于靶向给药。
Biomol Eng. 2005 Feb;21(6):145-55. doi: 10.1016/j.bioeng.2004.10.001. Epub 2004 Dec 9.